Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

PDS Biotechnology Corporation (PDSB)

Compare
1.2300
-0.1100
(-8.21%)
At close: March 7 at 4:00:01 PM EST
1.2400
+0.01
+(0.81%)
After hours: March 7 at 7:58:45 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
39,367.5860
43,045.2340
41,672.4210
21,439.3110
14,902.3860
Operating Income
-39,367.5860
-43,045.2340
-41,672.4210
-21,439.3110
-14,902.3860
Net Non Operating Interest Income Expense
-2,057.8290
-1,302.9830
-381.3390
4.3460
55.0060
Pretax Income
-41,425.4150
-44,348.2170
-42,053.7600
-21,434.9650
-14,847.3800
Tax Provision
-869.1670
-1,406.0190
-1,198.9050
-4,516.4880
--
Net Income Common Stockholders
-40,556.2480
-42,942.1980
-40,854.8550
-16,918.4770
-14,847.3800
Diluted NI Available to Com Stockholders
-40,556.2480
-42,942.1980
-40,854.8550
-16,918.4770
-14,847.3800
Basic EPS
-1.17
-1.39
-1.43
-0.66
-0.89
Diluted EPS
-1.17
-1.39
-1.43
-0.66
-0.89
Basic Average Shares
34,996.3920
30,952.0600
28,599.2210
25,597.1250
16,745.0440
Diluted Average Shares
34,996.3920
30,952.0600
28,599.2210
25,597.1250
16,745.0440
Total Operating Income as Reported
-39,367.5860
-43,045.2340
-41,672.4210
-21,439.3110
-14,902.3860
Total Expenses
39,367.5860
43,045.2340
41,672.4210
21,439.3110
14,902.3860
Net Income from Continuing & Discontinued Operation
-40,556.2480
-42,942.1980
-40,854.8550
-16,918.4770
-14,847.3800
Normalized Income
-40,556.2480
-42,942.1980
-40,854.8550
-16,918.4770
-14,847.3800
Interest Income
2,694.4140
2,902.9390
935.1800
4.3460
55.0060
Interest Expense
4,752.2430
4,205.9220
1,316.5190
--
--
Net Interest Income
-2,057.8290
-1,302.9830
-381.3390
4.3460
55.0060
EBIT
-36,673.1720
-40,142.2950
-40,737.2410
-21,434.9650
-14,902.3860
EBITDA
-36,652.7830
-40,124.9360
-40,737.1550
-21,429.6080
-14,886.7780
Reconciled Depreciation
20.3890
17.3590
0.0860
5.3570
15.6080
Net Income from Continuing Operation Net Minority Interest
-40,556.2480
-42,942.1980
-40,854.8550
-16,918.4770
-14,847.3800
Normalized EBITDA
-36,652.7830
-40,124.9360
-40,737.1550
-21,429.6080
-14,886.7780
Tax Rate for Calcs
0
0
0
0.0002
--
12/31/2020 - 9/30/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CTMX CytomX Therapeutics, Inc.
0.6649
+7.71%
 
ZVSA ZyVersa Therapeutics, Inc.
0.9800
+10.11%
 
DAWN Day One Biopharmaceuticals, Inc.
8.67
-4.73%
 
NKGN NKGen Biotech, Inc.
0.1913
0.00%
 
WINT Windtree Therapeutics, Inc.
1.9000
-6.86%
 
AEON AEON Biopharma, Inc.
0.6601
-7.03%
 
SLXN Silexion Therapeutics Corp
1.3300
+9.92%
 
MREO Mereo BioPharma Group plc
2.4900
-0.80%
 
PTIX Protagenic Therapeutics, Inc.
0.3222
-11.77%
 
MRKR Marker Therapeutics, Inc.
1.5000
-6.83%